A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Stopped early

Conditions studied: Solid Organ Tumors

In brief

The purpose of this research study is to collect information from patient's medical records that had a test called ChemoFx® ordered and to understand how doctors may have used the results of the ChemoFx® to treat patients with cancer.

Key facts

Study ID

NCT01271959

Run by

Precision Therapeutics

People needed

167

Starts

2010-11-01

Expected to finish

2012-10-01

Last updated by the study team

2012-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically confirmed diagnosis of solid tumor malignancy;
• Medically indicated to receive chemotherapy;
• Fresh tissue submitted from the solid tumor malignancy for testing with the ChemoFx® assay after August, 2006;
• Final ChemoFx® assay report is available;
• Subject must be at least 18 years of age;
• Subject must sign and date an IRB approved ICF.

You may not qualify if…

• Enrolled in PT-103, PT-106, PT-206, PT-301, or PT-304;
• Pregnant or lactating subjects;
• Subjects are not indicated to receive chemotherapy for their disease;
• Subjects with psychiatric or addictive disorders that would preclude obtaining informed consent.

Where it is running

• Cardio-Thoracic Surgeons, P.C. — Birmingham, Alabama, United States
• Hematology Oncology Associates — Oakland, California, United States
• Collaborative Research Group — Boynton Beach, Florida, United States
• Broward Oncology Associates, P.A. — Fort Lauderdale, Florida, United States
• The Center For Gynecologic Oncology — Hollywood, Florida, United States
• GYN Oncology of Miami — Miami, Florida, United States
• Miami International Surgical Services — Miami, Florida, United States
• Orlando Cardiovascular Institute PA — Orlando, Florida, United States
• Edward H. Kaplan, M.D. & Associates — Skokie, Illinois, United States
• Iowa Clinic — Des Moines, Iowa, United States
• Central Baptist Hospital Clinical Research Center — Lexington, Kentucky, United States
• Oncology Associates of West Kentucky — Paducah, Kentucky, United States
• Grand Blanc Surgical Specialist — Grand Blanc, Michigan, United States
• Albany Thoracic & Esophageal Surgery — Albany, New York, United States
• North Shore Hematology Oncology — East Setauket, New York, United States
• The New York Hospital Medical Center of Queens — Flushing, New York, United States
• Winthrop University Hospital — Mineola, New York, United States
• Center for Clinical Research and Technology University Hospitals of Cleveland — Cleveland, Ohio, United States
• The Regional Cancer Center — Erie, Pennsylvania, United States
• Barry S Siller MD — Houston, Texas, United States
• Colorectal Surgical Associates — Houston, Texas, United States
• Northwest Cancer Center — Houston, Texas, United States
• Cancer Care Centers of South Texas — San Antonio, Texas, United States
• Cancer Care Northwest — Spokane, Washington, United States
• Heiskell, King, Burns & Tallman Surgical Associates, Inc. — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.